Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Bibliográfalaš dieđut
Váldodahkki:	RECOVERY Collaborative Group
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Elsevier 2024

Methylprednisolone, intravenous immunoglobulin, tocilizimab or anakinra for children with Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS CoV-2 (PIMS-TS, MIS-C) – report from a randomised, controlled, open-label, platform trial
Dahkki: Haynes, R, et al.
Almmustuhtton: (2023)

COVID-19-Associated Paediatric Inflammatory Multisystem Syndrome (PIMS-TS) in Intensive Care: A Retrospective Cohort Trial (PIMS-TS INT)
Dahkki: Tereza Musilová, et al.
Almmustuhtton: (2023-02-01)

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dahkki: RECOVERY Collaborative Group
Almmustuhtton: (2021)

Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort
Dahkki: André Cavalcanti, et al.
Almmustuhtton: (2022-02-01)

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dahkki: RECOVERY Collaborative Group
Almmustuhtton: (2020)

30 Multisystem inflammatory syndrome in children (MIS-C/PIMS): an overview
Dahkki: Eunice Jia Lin Tang
Almmustuhtton: (2021-04-01)

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020
Dahkki: Jessica Flood, et al.
Almmustuhtton: (2021-04-01)

A national consensus management pathway for Paediatric Inflammatory Multisystem Syndrome - Temporally associated with SARS-CoV-2 (PIMS-TS): The results of a national Delphi process
Dahkki: Harwood, R, et al.
Almmustuhtton: (2020)

Swissped-RECOVERY: masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland
Dahkki: Andrew Atkinson, et al.
Almmustuhtton: (2024-04-01)

Cardiac involvement in children with paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): data from a prospective nationwide surveillance study
Dahkki: Anita Uka, et al.
Almmustuhtton: (2023-10-01)

Risk of paediatric multisystem inflammatory syndrome (PIMS-TS) during the SARS-CoV-2 alpha and delta variant waves: National observational and modelling study, 2020–21, England
Dahkki: Joseph Shingleton, et al.
Almmustuhtton: (2022-12-01)

Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome—Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial
Dahkki: Tatjana Welzel, et al.
Almmustuhtton: (2022-05-01)

Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the United Kingdom and Ireland: What is new?
Dahkki: Pier Paolo Bassareo
Almmustuhtton: (2021-04-01)

Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins: 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trialResearch in context
Dahkki: Maya C. Andre, et al.
Almmustuhtton: (2024-01-01)

A brand new medical condition - 6 years old patient with neurological symptoms diagnosed with PIMS-TS (Paediatric Inflammatory Multisystem Syndrome – Temporally Associated with SARS-CoV-2) - case report
Dahkki: Robert Dubel, et al.
Almmustuhtton: (2022-11-01)

Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee
Dahkki: Jaime Fernández-Sarmiento, et al.
Almmustuhtton: (2021-10-01)

Multisystem Inflammatory Syndrome in Children (MIS-C) in a Lithuanian Paediatric Tertiary Care Center
Dahkki: Indrė Stacevičienė, et al.
Almmustuhtton: (2024-10-01)

PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME (PIMS) AND DENGUE FEVER DURING SARS-COV-2 PANDEMIC
Dahkki: D. Bhat
Almmustuhtton: (2023-05-01)

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Dahkki: RECOVERY Collaborative Group, et al.
Almmustuhtton: (2022)

The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery
Dahkki: Eleni Syrimi, et al.
Almmustuhtton: (2021-11-01)

Fast recovery of cardiac function in PIMS-TS patients early using intravenous anti-IL-1 treatment
Dahkki: Maria Vincenza Mastrolia, et al.
Almmustuhtton: (2021-04-01)

Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
Dahkki: Dominic Worku
Almmustuhtton: (2023-03-01)

Multisystem inflammatory syndrome in children (MIS-C) and “Near MIS-C”: A continuum?
Dahkki: Sarah Khafaja, et al.
Almmustuhtton: (2023-01-01)

Anti-SARS-CoV-2 Vaccination and PIMS-TS—Friends or Foe? Case Reports and Literature Review
Dahkki: Violetta Opoka-Winiarska, et al.
Almmustuhtton: (2024-03-01)

Early recognition of PIMS-TS: a single centre retrospective review
Dahkki: Roshni Mistry, et al.
Almmustuhtton: (2021-10-01)

Neuro-PIMS-TS: a single case report and review of the literature
Dahkki: Antonio Scarcella, et al.
Almmustuhtton: (2022-12-01)

Acute Vision Loss and Conjunctival Hemorrhage as Telltale Symptoms of PIMS-TS
Dahkki: Houda Nassih PhD, et al.
Almmustuhtton: (2022-07-01)

Multisystem inflammatory syndrome associated with coronavirus disease 2019: MIS-C-concepts and MIS-concepts
Dahkki: Pradeep Kumar Sharma
Almmustuhtton: (2021-01-01)

Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations; a systematic review
Dahkki: Mohamed Elsaid, et al.
Almmustuhtton: (2023-11-01)

Demographic, clinical and laboratory differences between paediatric acute COVID-19 and PIMS-TS—results from a single centre study in the UK
Dahkki: Prince Jiju, et al.
Almmustuhtton: (2023-11-01)

Multisystem inflammatory syndrome in children (MIS-C) and long Covid
Dahkki: Yonca Bulut
Almmustuhtton: (2024-03-01)

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Dahkki: RECOVERY Collaborative Group, et al.
Almmustuhtton: (2021)

Manifestations of the pediatric multisystem inflammatory syndrome temporally related with SARS-CoV-2 (PIMS) in the gastrointestinal, cardiovascular, nervous and respiratory systems.
Dahkki: Anna Brzyska, et al.
Almmustuhtton: (2022-04-01)

The Role of Glucocorticoids in the Treatment of Multisystem Inflammatory Syndrome (MIS-C)—Data from POLISH MIS-C Registry
Dahkki: Ewelina Gowin, et al.
Almmustuhtton: (2022-02-01)

Multisystem inflammatory syndrome in neonates (MIS-N): an updated systematic review
Dahkki: Divya Muthiah, et al.
Almmustuhtton: (2024-07-01)

Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)
Dahkki: Johana Isaza-Correa, et al.
Almmustuhtton: (2023-09-01)

The Youngest Palestinian Case of Multisystem Inflammatory Syndrome in children (MIS-C)
Dahkki: Fawzy Mazen Abunejma, et al.
Almmustuhtton: (2022-12-01)

Multisystem inflammatory syndrome in children (MIS-C): a mini-review
Dahkki: Martina Giacalone, et al.
Almmustuhtton: (2021-09-01)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
Dahkki: E. Sedlin, et al.
Almmustuhtton: (2023-04-01)

Biochemical and cardiovascular predictors of PIMS-TS risk in children after COVID-19 recovery: preliminary results of the LATE-COVID-Kids Study
Dahkki: Izabela Jatczak-Pawlik, et al.
Almmustuhtton: (2022-02-01)

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

Geahča maid

Geahča maid